Intestinal ischemic preconditioning protects the intestine and reduces bacterial translocation

Shock

Volumn 18, Issue 5, 2002, Pages 476-480

  Aksöyek, Selim ^a   Cinel, Ismail ^a   Avlan, Dinçer ^a   Cinel, Leyla ^a   Öztürk, Candan ^a   Gürbüz, Polat ^a   Nayci, Ali ^a   Oral, Ugur ^a  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

iNOS; Intestinal injury; Ischemia reperfusion; Multiple organ failure; Nitric oxide

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT;

ANIMAL; ARTICLE; ESCHERICHIA COLI; ISCHEMIC PRECONDITIONING; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; PATHOLOGY; RAT; SEPSIS; SMALL INTESTINE; VASCULARIZATION; WISTAR RAT;

ANIMALS; ESCHERICHIA COLI; INTESTINE, SMALL; ISCHEMIC PRECONDITIONING; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; SEPSIS;

EID: 0036834625     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200211000-00016     Document Type: Article

References (36)

1. Moore FA: The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg 178:449-453, 1999.
2. Meakins JL, Marshall JC: The gastrointestinal tract: the "motor" of the multiple organ failure. Arch Surg 121:197-201, 1986.
3. Miner TJ, Tavaf-Motamen H, Stojadinovic A, Shea-Donohue T: Ischemia-reperfusion protects the rat small intestine against subsequent injury. J Surg Res 82:1-10 1999.
4. Swank GM, Deitch EA: Role of the gut multiple organ failure: bacterial translocation and permeability changes. World J Surg 20:411-417, 1996.
5. Mishima S, Xu D, Lu Q, Deitch EA: The relationship among nitric oxide production, bacterial translocation, and intestinal injury after endotoxin challange in vivo. J Trauma 44:175-182, 1998.
6. Deitch EA, Rutan R, Waymack JP: Bacterial tranlocation studies of mice and men. Am J Gastroenterol 93:277-278, 1998.
7. Willy C, Dahouk S, Starck C, Kaffenberger W, Gerngrob H, Plappert UG: DNA damage in human leukocytes after ischemia/reperfusion injury. Free Rad Biol Med 28:1-12, 2000.
8. Deitch EA, Specian RD, Berg RD: Endotoxin-induced bacterial translocation and mucosal permeability: role of xanthine oxidase, complement activation, and macrophage products. Crit Care Med 19:785-791, 1991.
9. Murray CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136, 1986.
10. McCallion K, Wattanasirichaigoon S, Gardiner KR, Fink MP: Ischemic preconditioning ameliorates ischemia- and reperfusion-induced hyperpermeability in rats. Shock 14(4):429-434, 2000.
11. Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB: Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol Heart Circ Physiol 251:H1306-H1315, 1986.
12. Isenberg HD: Clinical Microbiology Procedures Handbook. Washington, DC: ASM Press, 1992, pp 1.15.5-1.17.6.
13. Chiu CT, McArdle AH, Brown R, Scott H, Gurd F: Intestinal mucosal lesion in low-flow states. Arch Surg 101:478-483, 1970.
14. Kubes P: Polymorphonuclear leukocyte-endothelium interactions: a role for pro-inflammatory and anti-inflammatory molecules. Can J Physiol Pharmacol 71:88-92, 1993.
15. Rosales C, Juliano RL: Signal transduction by cell adhesion receptors in leukocytes. J Leukocyte Biol 57:189-194, 1995.
16. Lelli JL Jr, Pradhan S, Cobb LM: Prevention of postischemic injury in immature intestine by desferoxamine. J Surg Res 54(1):34-38, 1993.
17. Sola A, Hotter G, Prats N, Xaus C, Gelpi E, Catafau-Rosello J: Modification of oxidative stress in response to intestinal preconditioning. Transplantation 69: 767-772, 2000.
18. Sorrells DL, Friend C, Koltuksuz U, Courcoulas A, Boyle P, Garret MS, Watkins S, Rowe MI, Ford HR: Inhibition of nitric oxide with aminoguanidine reduces bacterial translocation after endotoxin challenge in vivo. Arch Surg 131:1155-1163, 1996.
19. Mishima S, Xu D, Lu Q, Deitch EA: Bacterial translocation is inhibited in inducible nitric oxide synthase knouckout mice after endotoxin challenge but not in a model of bacterial overgrowth. Arch Surg 132:1190-1195, 1997.
20. Nadler EP, Ford HR: Regulation bacterial translocation by nitric oxide. Pediatr Surg Int 16:165-168, 2000.
21. Crow JP, Beckman JS: Reactions between nitric oxide, superoxide and peroxynitrite: footprints of peroxynitrite in vivo. Adv Pharmacol 34:17-43, 1995.
22. Ford HR, Watkins SC, Reblock KK, Rowe MI: The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 32:275-282, 1992.
23. Maulik N, Engelman RM, Rousou JA, Flack JE, Deaton D, Das DK: Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation 100(Suppl II):11-369-11-375, 1999.
24. Nakamura M, Wang NP, Zhao ZQ, Wilcox JN, Thourani V, Guyton RA, Vinten-Johansen J: Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardivasc Res 45(3):661-670, 2000.
25. Hassoun PM, Yu FS, Zulueta JJ, White AC, Lanzillo JJ: Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine dehydrogenase. Am J Physiol 268:L809-L812, 1995.
26. Abraham E: NF-κB activation. Crit Care Med 28:N100-N104, 2000.
27. Blackwell TS, Blackwell TR, Holden EP, et al.: In vivo antioxidant treatment supresses nuclear factor-κB activation and neutrophilic lung inflammation. J Immunol 157:1630-1637, 1996.
28. Kim EJ, Jin HK, Kim YK, Lee HY, Lee SY, Lee KR, Zee OP, Han JW, Lee HW: Suppression by a sesquiterpene lactone from Carpesium divaricatum of inducible nitric oxide synthase by inhibiting nuclear factor-κB activation. Biochem Pharmacol 61(7):903-910, 2001.
29. Chen Y, Yang L, Lee TJ: Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-κβ activation. Biochem Pharmacol 59(11):1445-1457, 2000.
30. Qu XW, Wang H, De Plaen IG, Rozenfeld RA, Hsueh W: Neuronal nitric oxide synthase (NOS) regulates the expression of inducible NOS in rat small intestine via modulation of nuclear factor κB. FASEB J 15(2):439-446, 2001.
31. Suzuki Y, Deitch EA, Mishima S, Lu Q, Xu D: Inducible nitric oxide synthase gene knockout mice have increased resistance to gut injury and bacterial translocation after an intestinal ischemia-reperfusion injury. Crit Care Med 28(11): 3692-3696, 2000.
32. Banan A, Fields JZ, Zhang Y, Keshavarzian A: iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol Gastrointest Liver Physiol 280(6):G1234-G1246, 2001.
33. Tsuruma T, Yagihashi A, Watanabe N, Yajima T, Kameshima H, Araya J, Hirata K: Heat-shock protein-73 protects against small intestinal warm ischemia-reperfusion injury in the rat. Surgery 125:385-395, 1999.
34. Szabo C, Dawson VL: Role of poly(ADP-ribose) synthetase in inflammation and ischemia-reperfusion. TIPS 19:287-293, 1998.
35. Taner S, Cinel I, Ozer I, Onde U, Taner D, Koksoy C: Poly (ADP-ribose) synthetase inhibition reduces bacterial translocation in rats after endotoxin challenge. Shock 16(2):159-162, 2001.
36. Liaudet L, Yang Z, Al-Affar EB, Szabo C: Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase. Mol Med 7(6): 406-417, 2001.